These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30849440)

  • 1. Precision medicine in resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug.
    Mahomed S; Padayatchi N; Singh J; Naidoo K
    J Infect; 2019 Apr; 78(4):261-268. PubMed ID: 30849440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.
    Wollenberg K; Harris M; Gabrielian A; Ciobanu N; Chesov D; Long A; Taaffe J; Hurt D; Rosenthal A; Tartakovsky M; Crudu V
    BMC Infect Dis; 2020 Jan; 20(1):17. PubMed ID: 31910804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications.
    Mahomed S; Naidoo K; Dookie N; Padayatchi N
    Tuberculosis (Edinb); 2017 Dec; 107():137-143. PubMed ID: 29050762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment.
    Lange C; Chesov D; Heyckendorf J; Leung CC; Udwadia Z; Dheda K
    Respirology; 2018 Jul; 23(7):656-673. PubMed ID: 29641838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine for patients with MDR-TB.
    Olaru ID; Lange C; Heyckendorf J
    J Antimicrob Chemother; 2016 Apr; 71(4):852-5. PubMed ID: 26507429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis.
    Swaminathan S; Sundaramurthi JC; Palaniappan AN; Narayanan S
    Tuberculosis (Edinb); 2016 Dec; 101():31-40. PubMed ID: 27865394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diagnostics and therapeutics for drug-resistant tuberculosis.
    Toosky M; Javid B
    Br Med Bull; 2014 Jun; 110(1):129-40. PubMed ID: 24810849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen-based precision medicine for drug-resistant tuberculosis.
    Gröschel MI; Walker TM; van der Werf TS; Lange C; Niemann S; Merker M
    PLoS Pathog; 2018 Oct; 14(10):e1007297. PubMed ID: 30335850
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of resistance to anti-tuberculosis drugs in the clinical isolates of Mycobacterium tuberculosis from Slovakia through comparison between phenotypic and genetic methods and evaluation of resistance levels with clinical parameter.
    Mokry J; Porvaznik I; Kusnir P; Dohal M; Solovic I
    J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31172969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome Sequencing.
    Bryant JM; Lipman M; Breuer J
    Expert Rev Anti Infect Ther; 2016; 14(1):1-3. PubMed ID: 26559223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.
    Lohrasbi V; Talebi M; Bialvaei AZ; Fattorini L; Drancourt M; Heidary M; Darban-Sarokhalil D
    Tuberculosis (Edinb); 2018 Mar; 109():17-27. PubMed ID: 29559117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2015 Nov; 19(11):1276-89. PubMed ID: 26467578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible?
    Cox H; Hughes J; Black J; Nicol MP
    Lancet Infect Dis; 2018 Sep; 18(9):e282-e287. PubMed ID: 29548923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of genomic interrelatedness of publicly available samples in the TB portals database.
    Wollenberg KR; Jeffrey BM; Harris MA; Gabrielian A; Hurt DE; Rosenthal A
    Tuberculosis (Edinb); 2022 Mar; 133():102171. PubMed ID: 35101846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

  • 19. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
    Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.